Effects of anti-arthritis preparations on gene expression and enzyme activity of cyclooxygenase-2 in cultured equine chondrocytes.

This research investigates how anti-inflammatory compounds influence the gene expression and enzyme activity associated with inflammation and pain in horse joint cells. Results show that an anti-inflammatory called Dexamethasone effectively reduced gene expression responsible for inflammation, indicating a possible treatment path for equine arthritis.

Understanding the Research Methods

• The researchers used articular cartilage from 9 young adult horses for this study.
• To prepare a specific type of DNA probe, they utilized a laboratory technique known as Reverse transcriptase-polymerase chain reaction, specifically designed to amplify a section of equine COX-2. COX-2 is the gene that produces an enzyme triggering inflammation and pain.
• The researchers used Northern blot analysis, a method used to measure gene expression, to detect the level of COX-2 expression in horse joint cell cultures.
• The cell cultures were propagated in a medium containing one of four different anti-inflammatory compounds—dexamethasone (DEX), phenylbutazone (PBZ), polysulfated glycosaminoglycan, or hyaluronan, each at various concentrations. Some cultures also had recombinant equine interleukin -1beta (reIL-1beta), a protein that induces an immune response, added in.
• Lastly, the researchers measured the prostaglandin E2 (PGE2) concentrations, a compound linked with inflammation, in the culture medium using a commercial immunoassay—a laboratory technique that measures the concentration of a substance in a solution.

Key Findings from the Research

• The presence of reIL-1beta increased the expression of COX-2 in a dose-dependent manner, which was paralleled by an increased concentration of PGE2 in the culture medium.
• The concentration of PGE2 in the medium from reIL-beta-treated joint cells was significantly lowered by DEX and PBZ. However, only DEX significantly reduced the gene expression of COX-2.
• The conclusion drawn by the authors is that PGE2 plays a significant role in the pathophysiologic processes of arthritis, and joint cells in culture respond to interleukin-1 with an increase in expression and activity of COX-2. This suggests that relieving symptoms in affected horses might be partly due to inhibiting PGE2 synthesis. But, of the four tested compounds, only DEX affected the pretranslational regulation of the COX-2 gene in cultured equine joint cells.